BR0309676A - Dispositivo médico - Google Patents

Dispositivo médico

Info

Publication number
BR0309676A
BR0309676A BR0309676-9A BR0309676A BR0309676A BR 0309676 A BR0309676 A BR 0309676A BR 0309676 A BR0309676 A BR 0309676A BR 0309676 A BR0309676 A BR 0309676A
Authority
BR
Brazil
Prior art keywords
medical device
present
relates
nucleus
nucleic acid
Prior art date
Application number
BR0309676-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Olli-Pekka Leppaenen
Seppo Ylae-Herttuala
Mikko Laukkanen
Mika Lahtinen
Original Assignee
Fit Biotech Oyl Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2002/000848 external-priority patent/WO2002087610A1/fr
Application filed by Fit Biotech Oyl Plc filed Critical Fit Biotech Oyl Plc
Publication of BR0309676A publication Critical patent/BR0309676A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0309676-9A 2002-04-30 2003-04-30 Dispositivo médico BR0309676A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2002/000848 WO2002087610A1 (fr) 2001-04-30 2002-04-30 Dispositif medical
PCT/SE2003/000713 WO2003092727A1 (fr) 2002-04-30 2003-04-30 Dispositif medical

Publications (1)

Publication Number Publication Date
BR0309676A true BR0309676A (pt) 2005-02-22

Family

ID=29398638

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309676-9A BR0309676A (pt) 2002-04-30 2003-04-30 Dispositivo médico

Country Status (8)

Country Link
EP (1) EP1499344A1 (fr)
JP (1) JP2006503605A (fr)
KR (1) KR20050000416A (fr)
CN (1) CN1649620A (fr)
AU (1) AU2003224587A1 (fr)
BR (1) BR0309676A (fr)
CA (1) CA2483096A1 (fr)
WO (1) WO2003092727A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008045949A2 (fr) * 2006-10-10 2008-04-17 Celonova Biosciences, Inc. Valvule cardiaque bioprothétique à polyphosphazène
US7854941B2 (en) 2007-02-12 2010-12-21 The University Of Southern Mississippi Method of attaching drug compounds to non-reactive polymer surfaces
JP5581485B2 (ja) * 2007-03-22 2014-09-03 インダストリーアカデミック コーポレーション ファンデーション， ザ カトリックユニバーシティ オブ コリア Ｅｃ−ｓｏｄの新規な用途及びその製造方法
CN109602468B (zh) 2012-02-23 2021-10-01 高级缝合有限公司 改进的缝合线
US10278694B2 (en) 2012-02-23 2019-05-07 Northwestern University Indirect attachment of a needle to a mesh suture
KR102837963B1 (ko) 2020-02-25 2025-07-23 엘지전자 주식회사 공기조화기

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
US5171680A (en) * 1988-06-14 1992-12-15 Chiron Corporation Superoxide dismutase analogs having novel binding properties
FR2721943B1 (fr) * 1994-06-29 1996-08-02 Rhone Poulenc Rorer Sa Adenovirus comprenant un gene codant pour une superoxyde dismutase
AU704222B2 (en) * 1995-03-24 1999-04-15 Genzyme Corporation Reduction of adhesions using controlled delivery of active oxygen inhibitors
AU6905696A (en) * 1995-09-01 1997-03-27 Emory University Endovascular support device and method of use
WO1998030255A2 (fr) * 1997-01-09 1998-07-16 Localmed, Inc. Apport intravasculaire localise de substances antioxydantes pour l'inhibition de la restenose dans des vaisseaux sanguins recanalises
US6541116B2 (en) * 1998-01-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Superoxide dismutase or superoxide dismutase mimic coating for an intracorporeal medical device
WO2000024412A2 (fr) * 1998-10-26 2000-05-04 Ludwig Institute For Cancer Research Utilisation du gene ou de la proteine vegf-c ou vegf-d pour prevenir la restenose
WO2001021229A1 (fr) * 1999-09-23 2001-03-29 Lee Clarence C Stent endovasculaire (cardiovasculaire) a pouvoir antimicrobien et anti-inflammatoire
JP2003520830A (ja) * 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
WO2001054745A2 (fr) * 2000-01-25 2001-08-02 Edwards Lifesciences Corporation Revetements bioactifs de prevention de la proliferation tissulaire sur des valvules cardiaques artificielles
FI20010898A0 (fi) * 2001-04-30 2001-04-30 Ylae Herttuala Seppo Ekstrasellulaarinen superoksididismutaasi (EC-SOD) geeniterapia restenoosoin ehkäisemiseksi

Also Published As

Publication number Publication date
WO2003092727A1 (fr) 2003-11-13
AU2003224587A1 (en) 2003-11-17
JP2006503605A (ja) 2006-02-02
WO2003092727A9 (fr) 2005-01-20
CA2483096A1 (fr) 2003-11-13
KR20050000416A (ko) 2005-01-03
CN1649620A (zh) 2005-08-03
EP1499344A1 (fr) 2005-01-26

Similar Documents

Publication Publication Date Title
EP2166990B1 (fr) Dispositif de positionnement de tissu
BR0013042A (pt) Dispositivo para a execução de uma modificação biológica de um fluido, dispositivo para a execução de uma modificação biológica de um fluido de um ser vivo, dispositivo extra-corpóreo para proporcionar a um ser vivo uma ou mais funções hepáticas, dispositivo intra-corpóreo para proporcionar a um ser vivo uma ou mais funções hepáticas, dispositivo intra-corpóreo para proporcionar a um ser vivo uma ou mais funções renais, dispositivo intra-corpóreo para proporcionar a um ser vivo uma ou mais funções renais e hepáticas, dispositivo extra-corpóreo para proporcionar a um ser vivo uma ou mais funções renais, método para a execução de uma modificação biológica de um fluido a partir de um ser vivo, método para a preparação de um órgão planar contìnuo, método para proporcionar a um ser vivo uma ou mais funções hepáticas, método para proporcionar a um ser vivo uma ou mais funções renais, método para preparar e usar micropartes de órgão preservada por meio da técnica criogênica e método para proporcionar a um ser vivo uma ou mais funções renais e hepáticas
BRPI0410206A (pt) dispositivo de conexão para osteosìntese vertebral
BR0214162A (pt) Aparelho para cultura de organismo e processo para cultura de organismo
BR9711536A (pt) Composições elastoméricas de poliuretano contendo polisiloxano.
AR002043A1 (es) Utilizacion de agonistas de alfa (1l) para el tratamiento de la incontinencia urinaria.
BRPI0416305A (pt) método de seleção, método de determinação se um paciente mamìfero diagnosticado com cáncer é propenso a beneficiar-se do tratamento com antagonista de tgf-beta, método de tratamento de destruição ou perda óssea, métodos de tratamento de paciente mamìfero e kit que compreende um recipiente
ATE522178T1 (de) Elektrochirurgischen sonde mit einen schaft mit einem kanal für flüssigkeiten
DK1984006T3 (da) Konditioneret blodsammensætning og fremgangsmåde til produktion deraf
BR9917048A (pt) Procedimento e dispositivo para favorecer o implante de material biológico
Sun et al. Bio-chemo-mechanical coupling models of soft biological materials: A review
Hu et al. Wettability and biological responses of titanium surface’s biomimetic hexagonal microstructure
WO2001098539A3 (fr) Marqueurs genetiques destines au cancer du poumon
EP1535632A4 (fr) Materiau de reparation biologique compatible avec un adhesif pour tissu biologique
Kusaka et al. Fundamental study for all-ceramic artificial hip joint
Ammar et al. Neural tissue compatibility of Teflon as an implant material for microvascular decompression
DE60313718D1 (de) Zusammensetzung zur Zellkultur, die Polyethylenglykol enthält
ATE462359T1 (de) Einzelfalten-vorrichtung für die fixierung von gewebe
ATE333239T1 (de) Medizinischer spatel
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
JPH0761307B2 (ja) 生体内視用部材
Smiljanić CRP as an early predictor of neurosurgical site infections.
SCOTT et al. Haemagglutination and tissue culture adhesion of Gardnerella vaginalis
ES2817676B2 (es) Mascarilla biosanitaria antiulceral
Weiss et al. Fully differentiated chondrocytes alter their phenotypic expression in vitro and transform into bone cells

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]